Chemical Compound

(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1,5-dimethyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-hex-4-enyl]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol

CAS Registry Number 22427-39-0
返回搜索 申请报价
(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1,5-dimethyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-hex-4-enyl]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol 结构式
Primary record

(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1,5-dimethyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-hex-4-enyl]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol

库存
7,327 克
纯度
98.1 %
CAS
22427-39-0

化合物标识与属性

CAS
22427-39-0
PubChem CID
441923
SMILES
CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)O)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C
Canonical SMILES
CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C[C@]12C

名称与同义词

  • Ginsenoside RG1
  • Sanchinoside C1
  • Panaxoside A
  • Ginsenoside A2
  • Panaxoside Rg1
  • 22427-39-0
  • Sanchinoside Rg1
  • ginsenoside-Rg1
  • GinsenosideRG1
  • Ginsenoside g1
  • panaxosiderg1
  • Panaxoside A;
  • ginsenoside-Rg(1)
  • sanchinoside C(1)
  • Ginsenoside A2;
  • Ginsenoside Rg1;
  • Ginsenoside Rg1?
  • Sanchirhinoside A3
  • Ginsenoside Rg1 CRS
  • Ginsenoside Rg1 RS
  • (20S)-ginsenoside Rg1
  • RefChem:37717
  • AC1L9BXQ
  • G-Rg1
  • MFCD00210293
  • UNII-PJ788634QY
  • DTXSID70945111
  • PJ788634QY
  • Panaxoside A;Panaxoside Rg1
  • CHEBI:67987
  • BIDD:ER0075
  • Dammarane, -D-glucopyranoside
  • C42H72O14
  • YURJSTAIMNSZAE-HHNZYBFYSA-N
  • CHEMBL501637
  • orb1305031
  • SCHEMBL19875635
  • CTK8F0917
  • EINECS 244-989-9
  • GINSENOSIDE RG1 [USP-RS]
  • GINSENOSIDE RG1 [WHO-DD]
  • DTXCID701373437
  • HMS3885M12
  • EX-A6784
  • HY-N0045
  • MSK40042
  • CID441923
  • Ginsenoside Rg1, analytical standard
  • NP6987
  • s3923
  • AKOS037514672
  • ZINC238809655
  • ACN-035583
  • CCG-270492
  • CID:441923
  • CS-3832
  • DB06750
  • EBC-615478
  • OG09289
  • C42-H72-O14
  • NCGC00483065-01
  • BS-16671
  • GINSENOSIDE RG1 (REFERENCE GRADE)
  • J15.784H
  • SC-17275
  • SID:53786785
  • SY068756
  • Ginsenoside Rg1 (saponin of Panax ginseng)
  • TR-036193
  • (3beta,6alpha,12beta)-3,12-Dihydroxydammar-24-ene-6,20-diyl bis-beta-D-Glucopyranoside
  • FT-0626705
  • FT-0777122
  • G0533
  • N1613
  • NS00073634
  • Y0090
  • C08946
  • 427G390
  • A816192
  • C035054
  • Q2276594
  • (6)-beta-D-Glucopyranosyl-(20)-beta-D-glucopyranosyl-20S-protopanaxatriol
  • 7-HYDROXY-2-OXO-2H-CHROMENE-3-CARBOXYLICACIDAMIDE
  • Ginsenoside Rg1, primary pharmaceutical reference standard
  • (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
  • (3beta,6alpha,12beta)-3,12-Dihydroxydammar-24-ene-6,20-diylbis(beta-D-glucopyranoside)
  • beta-D-Glucopyranoside, (3beta,6alpha,12beta)-3,12-dihydroxy dammar-24-ene-6,20-diylbis-
  • beta-D-Glucopyranoside, (3beta,6alpha,12beta)-3,12-dihydroxydammar-24-ene-6,20-diyl bis-
  • Ginsenoside Rg1, 98%, from Panax ginseng C. A. Mey. - 5MG 5mg
  • (2S,3R,4S,5S,6R)-2-{[(2S)-2-[(1S,3aR,3bR,5S,5aR,7S,9aR,9bR,11R,11aR)-7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-5-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-en-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
  • 6alpha,20-Bis(beta-D-glucopyranosyloxy)dammara-24-ene-3beta,12beta-diol
  • Ginsenoside Rg1, United States Pharmacopeia (USP) Reference Standard
  • (3?,6?,12?)-3,12-Dihydroxydammar-24-ene-6,20-diylbis-?-D-glucopyranoside
  • (3|A,6|A,12|A)-3,12-Dihydroxydammar-24-ene-6,20-diyl bis-|A-D-glucopyranoside
  • (3b,6a,12b)-3,12-Dihydroxydammar-24-ene-6,20-diyl bis-b-D-glucopyranoside
  • (3beta,6alpha,12beta)-3,12-dihydroxydammar-24-ene-6,20-diylbis[beta-D-glucopyranoside]
  • (6)-.BETA.-D-GLUCOPYRANOSYL-(20)-.BETA.-D-GLUCOPYRANOSYL-20S- PROTOPANAXATRIOL
  • [3beta,12beta-Dihydroxy-5alpha-dammar-24-ene-6alpha,20-diyl]bis(beta-D-glucopyranoside)
  • 3beta,12beta-Dihydroxy-5alpha-dammar-24-ene-6alpha,20-diylbis(beta-D-glucopyranoside)
  • (20S)-6alpha-(beta-D-Glucopyranosyloxy)-20-(beta-D-glucopyranosyloxy)dammara-24-ene-3beta,12beta-diol
  • (2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-((2S)-6-methyl-2-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxyhept-5-en-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-6-yl)oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
  • (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1,5-dimethyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-hex-4-enyl]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
  • (2R,3R,4S,5S,6R)-2-{[(1S,3AR,3BR,5S,5AR,7S,9AR,9BR,11R,11AR)-7,11-DIHYDROXY-3A,3B,6,6,9A-PENTAMETHYL-1-[(2S)-6-METHYL-2-{[(2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL]OXY}HEPT-5-EN-2-YL]-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-5-YL]OXY}-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL
  • (3.BETA.,6.ALPHA.,12.BETA.)-3,12-DIHYDROXYDAMMAR-24-ENE-6,20- DIYLBIS(.BETA.-D-GLUCOPYRANOSIDE)
  • (3beta,alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl beta-D-glucopyranoside
  • .BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,6.ALPHA.,12.BETA.)-3,12- DIHYDROXY DAMMAR-24-ENE-6,20-DIYLBIS-
  • .BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,6.ALPHA.,12.BETA.)-3,12-DIHYDROXYDAMMAR-24-ENE-6,20-DIYL BIS-
  • 20-(beta-D-Glucopyranosyloxy)-3beta,12beta-dihydroxy-5alpha-dammara-24-ene-6alpha-yl beta-D-glucopyranoside
  • 244-989-9
  • 6alpha-(beta-D-Glucopyranosyloxy)-3beta,12beta-dihydroxydammar-24-en-20-yl beta-D-glucopyranoside
  • GINSENOSIDE RG1 (CONSTITUENT OF AMERICAN GINSENG, ASIAN GINSENG, AND TIENCHI GINSENG) [DSC]
  • RG1